MX2021000339A - Solubilizado con curcumina y al menos un cannabinoide como sustancia activa adicional. - Google Patents
Solubilizado con curcumina y al menos un cannabinoide como sustancia activa adicional.Info
- Publication number
- MX2021000339A MX2021000339A MX2021000339A MX2021000339A MX2021000339A MX 2021000339 A MX2021000339 A MX 2021000339A MX 2021000339 A MX2021000339 A MX 2021000339A MX 2021000339 A MX2021000339 A MX 2021000339A MX 2021000339 A MX2021000339 A MX 2021000339A
- Authority
- MX
- Mexico
- Prior art keywords
- solubilisate
- cannabinoid
- polysorbate
- active agent
- further active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
Abstract
Con el fin de poner a disposición del organismo humano las propiedades curativas y promotoras de la salud de la curcumina y/o los cannabinoides, la invención proporciona un solubilizado que consiste en o comprende curcumina en un contenido igual o inferior al 10% en peso, y al menos un cannabinoide como al menos otra sustancia activa, así como al menos un emulsionante con un valor de HLB en un intervalo por debajo de 18, preferiblemente entre 13 y 18, en particular polisorbato 80 o polisorbato 20 o al menos un éster de sacarosa de ácidos grasos comestibles, y un solubilizado que comprende, en particular que consiste en al menos un cannabinoide en un contenido menor o igual al 10% en peso y al menos un emulsionante que tiene un valor 10 HLB en un intervalo de menos de 18, preferiblemente entre 13 y 18, en particular polisorbato 80 o polisorbato 20 o al menos un éster de sacarosa de ácidos grasos comestibles.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2017/067381 WO2019011414A1 (de) | 2017-07-11 | 2017-07-11 | Solubilisat mit curcumin und boswellia |
PCT/EP2017/067382 WO2019011415A1 (de) | 2017-07-11 | 2017-07-11 | SOLUBILISAT MIT CURCUMIN, XANTHOHUMOL UND SÜßHOLZWURZELEXTRAKT |
DE102017115496.5A DE102017115496A1 (de) | 2017-07-11 | 2017-07-11 | Süßholzwurzelextrakt-Solubilisat |
PCT/EP2018/068731 WO2019011955A2 (de) | 2017-07-11 | 2018-07-11 | Solubilisat mit curcumin und optional zumindest einem weiteren wirkstoff |
PCT/EP2019/068537 WO2020011854A1 (de) | 2018-07-11 | 2019-07-10 | Solubilisat mit curcumin und zumindest einem cannabinoid als weiterem wirkstoff |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021000339A true MX2021000339A (es) | 2021-03-25 |
Family
ID=62837944
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021000339A MX2021000339A (es) | 2017-07-11 | 2019-07-10 | Solubilizado con curcumina y al menos un cannabinoide como sustancia activa adicional. |
MX2021000385A MX2021000385A (es) | 2017-07-11 | 2019-07-10 | Solubilizado con curcumina y al menos el cannabinoide thc como una sustancia activa adicional. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021000385A MX2021000385A (es) | 2017-07-11 | 2019-07-10 | Solubilizado con curcumina y al menos el cannabinoide thc como una sustancia activa adicional. |
Country Status (19)
Country | Link |
---|---|
US (6) | US11197834B2 (es) |
EP (2) | EP3651804B1 (es) |
JP (1) | JP2020529974A (es) |
KR (1) | KR20200029002A (es) |
CN (2) | CN111201041A (es) |
BR (1) | BR112020000398A2 (es) |
CA (2) | CA3069621C (es) |
DK (3) | DK3651805T3 (es) |
ES (3) | ES2960296T3 (es) |
FI (2) | FI3651804T3 (es) |
HR (3) | HRP20231591T1 (es) |
HU (4) | HUE064518T2 (es) |
MX (2) | MX2021000339A (es) |
PL (3) | PL3651804T3 (es) |
PT (2) | PT3651804T (es) |
RS (3) | RS64650B1 (es) |
RU (2) | RU2752078C1 (es) |
UA (1) | UA125552C2 (es) |
WO (3) | WO2019011990A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2960296T3 (es) * | 2017-07-11 | 2024-03-04 | Aquanova Ag | Solubilizado con curcumina y boswelia y xantohumol |
DK3820527T3 (da) | 2018-07-11 | 2023-09-25 | Aquanova Ag | Xanthohumol-solubilisat |
DE202019104734U1 (de) * | 2019-08-29 | 2020-12-01 | Aquanova Ag | Folsäure-Solubilisat |
WO2023282783A1 (ru) * | 2021-07-09 | 2023-01-12 | Акционерное Общество "Акванова Рус" | Мицеллированный раствор активного компонента на основе экстракта лакрицы, способ его получения и применения |
WO2023224134A1 (ko) * | 2022-05-16 | 2023-11-23 | 주식회사 다미래 | 수용화 커큐민과 보스웰리아 추출물을 이용한 인지 능력 개선용 조성물 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07165588A (ja) | 1993-12-13 | 1995-06-27 | Tsumura & Co | 脳機能改善剤 |
US5744161A (en) | 1995-02-24 | 1998-04-28 | Sabinsa Corporation | Use of piperine as a bioavailability enhancer |
US5629351A (en) * | 1995-04-13 | 1997-05-13 | Council Of Scientific & Industrial Research | Boswellic acid compositions and preparation thereof |
EP1358876B1 (de) | 2002-04-30 | 2007-11-07 | Cognis IP Management GmbH | Mikrokapseln mit Anti-Aknewirkstoffen |
DK1431385T3 (da) * | 2002-12-18 | 2006-07-31 | Doehler Gmbh | Xanthohumolholdig drik |
WO2005092352A1 (fr) | 2004-03-26 | 2005-10-06 | Jianzhong Zhu | Procede de production utilisations de preparation liposomique de medecine chinoise pour le traitement de l'hepatite b virale et pour la prevention et le traitement de la fibration des cellules hepatiques |
DE102006024911A1 (de) * | 2006-05-24 | 2007-11-29 | Aquanova Ag | Boswellinsäure-Konzentrat |
EP1904042A2 (de) | 2005-07-08 | 2008-04-02 | Aquanova Ag | Wirkstoffextrakt-solubilisate |
DK1903866T3 (en) | 2005-11-07 | 2016-07-25 | Murty Pharmaceuticals Inc | Improved release of tetrahydrocannabinol |
WO2007058480A1 (en) | 2005-11-16 | 2007-05-24 | Md Bioalpha Co., Ltd. | Composition having effect on treatment and prevention of diseases syndrome treatment with glabridin |
TW200806306A (en) | 2006-02-24 | 2008-02-01 | Kaneka Corp | Oil-in-water emulsion composition containing licorice-derived polyphenol |
TW200808333A (en) * | 2006-04-17 | 2008-02-16 | Kaneka Corp | Licorice polyphenol preparation |
GB0623838D0 (en) | 2006-11-29 | 2007-01-10 | Malvern Cosmeceutics Ltd | Novel compositions |
DE102006062264A1 (de) | 2006-12-22 | 2008-06-26 | Joh. Barth & Sohn Gmbh & Co. Kg | Verwendung von Xanthohumol zur Vorbeugung und/oder Bekämpfung von Lebererkrankungen |
US9241893B2 (en) | 2007-11-19 | 2016-01-26 | Stiefel Laboratories, Inc. | Topical cosmetic skin lightening compositions and methods of use thereof |
EP2274411A4 (en) | 2008-04-11 | 2016-01-20 | Betal Llc | XANTHOHUMOL COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES OR CONDITIONS |
ES2316312B1 (es) | 2008-06-20 | 2010-02-08 | Ignacio Umbert Millet | Composicion farmaceutica dermatologica para el tratamiento de patologias de inflamacion de la piel, tales como por ejemplo dermatitis, dermatitis atopica, vitiligo, alopecia areata, acne, psoriasis y prurito,y combinaciones de las mismas. |
EP2192160B1 (de) * | 2008-12-01 | 2016-08-17 | Aquanova Ag | Micellar integrierter Oxidationsschutz für natürliche Farbstoffe |
US20110086017A1 (en) * | 2009-10-08 | 2011-04-14 | Svetlana Kravets | Medical Food composition and methods for management of inflammatory processes in mammals |
WO2012093524A1 (ja) | 2011-01-06 | 2012-07-12 | 花王株式会社 | 水中油型乳化組成物 |
WO2013009928A1 (en) * | 2011-07-11 | 2013-01-17 | Organic Medical Research | Cannabinoid formulations |
DE202012012130U1 (de) | 2012-12-19 | 2014-03-21 | Aquanova Ag | Curcuminsolubilisat |
US10213391B2 (en) | 2014-05-06 | 2019-02-26 | Mewa Singh | Pharmaceutical compositions comprising hemp and turmeric to treat pain and inflammation |
US20160008298A1 (en) * | 2014-07-14 | 2016-01-14 | Oregon State University | Xanthohumol-based compounds and compositions thereof, and methods of making and using the same |
WO2016022936A1 (en) | 2014-08-07 | 2016-02-11 | Murty Pharmaceuticals, Inc. | An improved oral gastrointestinal dosage form delivery system of cannabinoids and/or standardized marijuana extracts |
US20160081975A1 (en) * | 2014-09-18 | 2016-03-24 | Virun, Inc. | Soft gel compositions and pre-gel concentrates |
IL248149B (en) | 2016-09-29 | 2020-03-31 | Garti Nissim | Formulations of dilutable cannabinoids and processes for their preparation |
CN106619588B (zh) * | 2016-12-29 | 2019-08-16 | 厦门金达威生物科技有限公司 | 一种含辅酶q10的自微乳型营养组合物、制备方法及用途 |
GB2559774B (en) * | 2017-02-17 | 2021-09-29 | Gw Res Ltd | Oral cannabinoid formulations |
ES2960296T3 (es) | 2017-07-11 | 2024-03-04 | Aquanova Ag | Solubilizado con curcumina y boswelia y xantohumol |
WO2019011415A1 (de) | 2017-07-11 | 2019-01-17 | Aquanova Ag | SOLUBILISAT MIT CURCUMIN, XANTHOHUMOL UND SÜßHOLZWURZELEXTRAKT |
-
2018
- 2018-07-11 ES ES18737623T patent/ES2960296T3/es active Active
- 2018-07-11 DK DK18738321.1T patent/DK3651805T3/da active
- 2018-07-11 PT PT187376231T patent/PT3651804T/pt unknown
- 2018-07-11 US US16/629,155 patent/US11197834B2/en active Active
- 2018-07-11 BR BR112020000398-0A patent/BR112020000398A2/pt active Search and Examination
- 2018-07-11 PL PL18737623.1T patent/PL3651804T3/pl unknown
- 2018-07-11 RS RS20230894A patent/RS64650B1/sr unknown
- 2018-07-11 DK DK18737623.1T patent/DK3651804T5/da active
- 2018-07-11 JP JP2020501208A patent/JP2020529974A/ja active Pending
- 2018-07-11 US US16/629,077 patent/US11344509B2/en active Active
- 2018-07-11 WO PCT/EP2018/068801 patent/WO2019011990A1/de active Application Filing
- 2018-07-11 EP EP18737623.1A patent/EP3651804B1/de active Active
- 2018-07-11 PL PL18738321.1T patent/PL3651805T3/pl unknown
- 2018-07-11 CA CA3069621A patent/CA3069621C/en active Active
- 2018-07-11 PT PT187383211T patent/PT3651805T/pt unknown
- 2018-07-11 HU HUE18738321A patent/HUE064518T2/hu unknown
- 2018-07-11 WO PCT/EP2018/068731 patent/WO2019011955A2/de active Search and Examination
- 2018-07-11 WO PCT/EP2018/068729 patent/WO2019011954A1/de active Application Filing
- 2018-07-11 CN CN201880046608.4A patent/CN111201041A/zh active Pending
- 2018-07-11 ES ES18738321T patent/ES2965739T3/es active Active
- 2018-07-11 FI FIEP18737623.1T patent/FI3651804T3/en active
- 2018-07-11 HR HRP20231591TT patent/HRP20231591T1/hr unknown
- 2018-07-11 HR HRP20231160TT patent/HRP20231160T1/hr unknown
- 2018-07-11 KR KR1020207004082A patent/KR20200029002A/ko not_active Application Discontinuation
- 2018-07-11 HU HUE18737623A patent/HUE063380T2/hu unknown
- 2018-07-11 CN CN201880046265.1A patent/CN111163806A/zh active Pending
- 2018-07-11 EP EP18738321.1A patent/EP3651805B1/de active Active
- 2018-07-11 RU RU2020106042A patent/RU2752078C1/ru active
- 2018-07-11 CA CA3148455A patent/CA3148455A1/en active Pending
-
2019
- 2019-07-10 US US17/258,397 patent/US20220133682A1/en active Pending
- 2019-07-10 PL PL19736735.2T patent/PL3820529T3/pl unknown
- 2019-07-10 MX MX2021000339A patent/MX2021000339A/es unknown
- 2019-07-10 UA UAA202100177A patent/UA125552C2/uk unknown
- 2019-07-10 RS RS20230897A patent/RS64642B1/sr unknown
- 2019-07-10 MX MX2021000385A patent/MX2021000385A/es unknown
- 2019-07-10 ES ES19736735T patent/ES2960689T3/es active Active
- 2019-07-10 HU HUE19736735A patent/HUE063382T2/hu unknown
- 2019-07-10 HR HRP20231135TT patent/HRP20231135T1/hr unknown
- 2019-07-10 DK DK19736404.5T patent/DK3820528T3/da active
- 2019-07-10 FI FIEP19736404.5T patent/FI3820528T3/en active
- 2019-07-10 RU RU2021103127A patent/RU2771527C1/ru active
- 2019-07-10 US US17/258,363 patent/US20220133646A1/en active Pending
- 2019-07-10 HU HUE19736404A patent/HUE063768T2/hu unknown
- 2019-07-10 RS RS20230868A patent/RS64636B1/sr unknown
-
2021
- 2021-12-07 US US17/544,808 patent/US11931322B2/en active Active
-
2022
- 2022-04-27 US US17/730,356 patent/US20220249400A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021000339A (es) | Solubilizado con curcumina y al menos un cannabinoide como sustancia activa adicional. | |
BR112017025339A2 (pt) | composições nutricionais contendo um nível elevado de inositol e usos das mesmas | |
PH12019502709A1 (en) | A food product and method of manufacture | |
NZ611819A (en) | Nutritional products including a novel fat system including monoglycerides | |
PH12017500381A1 (en) | Optimized nutrient food | |
WO2018093238A3 (ko) | 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물 | |
EA201491269A1 (ru) | Низкобелковое замороженное кондитерское изделие | |
BR112018070060A2 (pt) | composições para tratamento bucal com uma exibição de sabor eficiente | |
PE20201182A1 (es) | Metodo para el tratamiento y control de fisiopatias de postcosecha de frutas mediante recubrimientos comestibles | |
ES2721761T3 (es) | Composición de baño de espuma | |
MX2019007796A (es) | Recubrimiento y/o pelicula comestible para la conservacion de productos carneos. | |
PH12019500275A1 (en) | Composition for imparting/enhancing cheese flavor, method for producing composition for imparting/enhancing cheese flavor, method for imparting cheese flavor to foods or enhancing cheese flavor of foods, and method for producing foods with imparted/enhanced cheese flavor | |
BR112018001580A2 (pt) | composição que compreende compostos de modulação de sabor, o uso dos mesmos e produto alimentício que compreende os mesmos | |
BR112015024064A2 (pt) | composição de isca macia rodenticida e método de preparação da composição | |
PH12015501139A1 (en) | A method of preparing an edible oil-in-water emulsion and emulsion so obtained | |
WO2018093237A3 (ko) | 포름산 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물 | |
PH12020500358A1 (en) | Oiliness/fattiness enhancer for foods, and food containing same | |
AU2019268060A1 (en) | Novel food product and method of use | |
BR112017019177A2 (pt) | emulsão, produto alimentício, formulação, uso de uma formulação, gotículas aquosas e processo | |
WO2016195016A8 (ja) | 新規なトリグリセリド及びその用途 | |
MX2017009098A (es) | Manufactura de confiteria congelada. | |
BR112013002176A2 (pt) | recheio de gorgura com gordura vegetal e adoçante | |
WO2019073127A3 (fr) | Composition contenant de l'huile du cannabis | |
WO2014145720A3 (en) | Fat emulsion providing taste masking | |
MX2015000210A (es) | Productos alimenticios horneados que tienen una textura aireada, blanda, suave y humeda. |